The use of AI is spreading rapidly while the wave of digitization has been changing the medical field, healthcare and life sciences industries.
EY Japan’s Life Sciences Sector is excited to present this life science symposium highlighting the latest trends in the industry, focusing on the use of AI .
First, Mr. Shingo Kurobane, Director for the Health Science Division of Health, Labour and Welfare of Japan, will discuss the latest governmental efforts related to AI in the medical field. We will then welcome the CEO & President of Interprotein Corporation and introduce the specific cases of AI drug discovery. In conclusion, we will showcase five trends for recent digital technologies at global life science companies, focusing on AI by EY’s Life Sciences Sector Global Leader, Pamela Spence,
|Hironao Yazaki, EY Japan Life Sciences Sector Leader|
|13:35-14:15||Keynote Speech: Use of AI in the medicine in Japan|
|Mr. Shingo Kurobane , Director for Health Science Division, MHLW|
|14:15-14:55||The recent case of AI Drug Discovery|
|Mr. Masato Hosoda , CEO & President of Interprotein Corporation|
|14:55-15:30||Digital Technologies at Global Life Science Companies|
|Pamela Spence, EY Global Life Sciences Industry Leader|
※Please be advised that the program is subject to change depending on the circumstances.
* Simultaneous interpretation will be available.
Please fill in the necessary item on the “Application Form” from button below and apply.
EY Japan Life Science Sector
TEL: 080 6855 8617